UNITED THERAPEUTICS Corp (UTHR) › EPS (Basic)UNITED THERAPEUTICS Corp (UTHR) — EPS (Basic)Annual figures by period end, from SEC filings.2008-12-31: $-1.082009-12-31: $0.372010-12-31: $1.892011-12-31: $3.812012-12-31: $5.842013-12-31: $3.492014-12-31: $7.062015-12-31: $14.172016-12-31: $16.292017-12-31: $9.502018-12-31: $13.542019-12-31: $-2.392020-12-31: $11.652021-12-31: $10.602022-12-31: $15.982023-12-31: $21.042024-12-31: $26.442025-12-31: $30.13$30.132008-12-31EPS (Basic) (USD/shares)2025-12-31Period endedEPS (Basic)Change YoYSource filing2025-12-31$30.13+14.0%2026-02-25From 2025-01-012024-12-31$26.44+25.7%2026-02-25From 2024-01-012023-12-31$21.04+31.7%2026-02-25From 2023-01-012022-12-31$15.98+50.8%2025-02-26From 2022-01-012021-12-31$10.60-9.0%2024-02-21From 2021-01-012020-12-31$11.65—2023-02-22From 2020-01-012019-12-31$-2.39-117.7%2022-02-24From 2019-01-012018-12-31$13.54+42.5%2021-02-24From 2018-01-012017-12-31$9.50-41.7%2020-02-26From 2017-01-012016-12-31$16.29+15.0%2019-02-27From 2016-01-012015-12-31$14.17+100.7%2018-02-21From 2015-01-012014-12-31$7.06+102.3%2017-02-22From 2014-01-012013-12-31$3.49-40.2%2016-02-25From 2013-01-012012-12-31$5.84+53.3%2015-02-24From 2012-01-012011-12-31$3.81+101.6%2014-02-25From 2011-01-012010-12-31$1.89+410.8%2013-02-26From 2010-01-012009-12-31$0.37—2012-02-28From 2009-01-012008-12-31$-1.08—2011-02-24From 2008-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted Shares